Exact Sciences Beats Q2 Estimates Despite a COVID-19 Drag
Exact Sciences (NASDAQ: EXAS) hasn't fired up investors so far in 2020 like it did last year. The good news is that Exact Sciences' management team said that there were signs of improvement in the quarterly conference call in May. Here are the highlights from Exact Sciences' Q2 update.